跳至主要内容
临床试验/NCT04814524
NCT04814524已完成不适用

A Digital Intervention Protocol to Enhance Recovery After Head and Neck Surgery

OHSU Knight Cancer Institute2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2021年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
2
主要终点
Mean daily opioid use

研究概览

简要总结

This trial studies examines the impact of virtual reality (VR) experiences and Fitbit wearable activity devices on postoperative recovery after head and neck surgery. Virtual reality has shown to help rehabilitation and pain control primarily in non-surgical fields, and researchers are interested in using this to help postoperative pain control. Early mobilization after surgery is also important, and may increase lung capacity, improve gastrointestinal function, reduce pain, and reduce risk of deep venous thrombosis. Use of virtual reality and Fitbit devices may improve postoperative pain control and reduce narcotic use among hospitalized patients after head and neck surgery.

详细描述

PRIMARY OBJECTIVES:

I. Evaluate the effectiveness of daily virtual reality (VR) therapy during hospitalization, compared to patients not utilizing daily VR therapy.

II. Evaluate the effectiveness of daily ambulation goals using Fitbit devices during hospitalization, compared to patients without daily ambulation goals.

III. Evaluate the effectiveness of daily VR use and daily Fitbit ambulation goals during hospitalization.

EXPLORATORY OBJECTIVES:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 89 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • English speaking (Ability to interact with virtual reality content may be impacted by inability to understand English)
  • Older than 18 years of age and younger than 89 years of age. Both men and women and members of all races and ethnic groups will be included
  • Planned to undergo major surgery at Oregon Health & Science University (OHSU) with the Department of Otolaryngology-Head and Neck Surgery with an expected length of stay (LOS) of 2 days or more
  • Ability to understand and the willingness to sign a written informed consent document

排除标准

  • Planned postoperative admission to the intensive care unit (ICU)
  • Social or psychiatric conditions that may interfere with compliance
  • Isolation precautions
  • Complex head and neck procedure requiring resection or reconstruction involving the scalp, orbit, or mid-face. This would limit the ability to utilize the VR headset
  • Reconstruction, incisions, wounds, wound care, or injury that impact the ability to place on the VR headset or wear a Fitbit device around the wrist. This would limit the ability to utilize the VR headset or the Fitbit device
  • History of seizure or epilepsy
  • History of vertigo or persistent dizziness
  • Use of cardiac pacemaker, requirement for hearing aid on at all times, or have defibrillators
  • Limitations that impair mobility. This would limit the ability to utilize the Fitbit device
  • Use of a walker or wheelchair at baseline. This would limit the ability to utilize the Fitbit device
  • Pregnant women
  • Neonates of uncertain viability or nonviable neonates
  • Decisionally impaired adults
  • Prisoners

结局指标

主要结局

Mean daily opioid use

时间窗: Through study completion, an average of 10 days

Will be assessed using milligram morphine equivalents (MME). Narcotic use may be compared using One-Way Analysis of Variance (ANOVA) and two sample t-test can be used to compare the narcotic use between intervention group and control group (virtual reality \[VR\]+Fitbit versus \[vs.\] control, VR vs. control, Fitbit vs. control). Furthermore, a linear regression model including demographic and clinical characteristic variables with a P-value =\< 0.1 will be used to determine factors associated with reduced narcotic use.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ryan Li, MD

Principal Investigator

OHSU Knight Cancer Institute

研究点 (2)

Loading locations...

相似试验